Trileaflet Mechanical Prosthetic Valve With Opening-Angle Stops

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing mechanical prosthetic heart valves do not mimic the natural human heart valve shape, leading to blood turbulence, increased coagulation risk, and wear and tear due to improper leaflet movement, necessitating anticoagulant use and potential malfunction.

Innovation Solution

A trileaflet mechanical prosthetic heart valve design with a ring, three hinges, and three leaflets, featuring protrusions to limit leaflet opening to 90° or less, ensuring laminar blood flow and independent movement, reducing turbulence and wear.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If traditional mechanical prosthetic heart valves are used, then durability is improved, but blood turbulence increases leading to coagulation risk

Engineering Contradiction:
Improvevalve durabilityVSAvoidblood turbulence and coagulation risk
Core Design Contradiction:
Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent copies the natural human heart valve shape and structure, specifically using a trileaflet design that mimics the natural valve's three cusps. This copying approach allows the mechanical valve to achieve laminar blood flow similar to natural valves, reducing turbulence and coagulation risk while maintaining the durability of mechanical materials.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent changes the geometric parameters of the valve leaflets to match natural heart valve dimensions and curvature. By adjusting the leaflet shape, size, and arrangement to replicate natural valve parameters, the design achieves physiological blood flow patterns that minimize turbulence while using durable mechanical materials.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If leaflets are allowed to open beyond threshold angle, then blood flow passage is improved, but leaflets get stuck in opened position

Engineering Contradiction:
Improveblood flow passageVSAvoidleaflet closing reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent incorporates a stop mechanism that prevents the leaflets from opening beyond a predetermined threshold angle (typically 90-120 degrees). This preliminary constraint stops the harmful action of over-opening before it can occur, ensuring that backward blood flow cannot push the leaflets past the safe angle and hold them in an incorrectly open position.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The stop mechanism provides mechanical feedback to the leaflet system by physically limiting the opening angle. When the leaflet approaches the threshold angle, the stop mechanism engages to prevent further opening, creating a self-regulating system that maintains reliable closing function while allowing sufficient opening for blood flow.

Inventive Principle:
Principle #23Feedback

3Ease of operation

If leaflets are attached to hinges, then movement is enabled, but wear and tear occurs at the interface

Engineering Contradiction:
Improveleaflet movementVSAvoidvalve lifespan
Core Design Contradiction:
Ease of operationVSDuration of action of stationary object

Solution Approach 1:

The patent extracts the hinge component from the valve design, eliminating the leaflet-hinge interface that causes wear and tear. By removing the hinge entirely and using an alternative attachment mechanism, the design maintains leaflet movement capability while eliminating the source of mechanical wear that limits valve lifespan.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces a new intermediary structure between the leaflet and the valve body that eliminates the need for traditional hinges. This intermediary mechanism provides the necessary movement function without creating a high-stress interface, thereby extending the valve's operational life while maintaining ease of leaflet operation.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Object-affected harmful factors

If anticoagulants are used to prevent clots, then coagulation risk is reduced, but patient treatment complexity increases

Engineering Contradiction:
Improvecoagulation riskVSAvoidtreatment complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

By copying the natural heart valve's shape and flow characteristics, the patent creates a mechanical valve that produces laminar blood flow similar to natural valves. This reduces blood stasis and turbulence, thereby lowering coagulation risk and potentially reducing or eliminating the need for lifelong anticoagulant therapy, simplifying patient treatment.

Inventive Principle:
Principle #26Copying

Data Source

PatentUS20250312147A1Trileaflet mechanical prosthetic heart valve
Publication Date: 2025.10.09 CLOVER LIFE SCIENCES INC
  • US20250312147A1 patent drawing
  • US20250312147A1 patent drawing
  • US20250312147A1 patent drawing

AI summary

A mechanical prosthetic heart valve having a ring, multiple hinges, and multiple leaflets. The hinges are attached to the ring and are evenly spaced from one another along the inner circumference of the ring. Each leaflet is rotably attached to a hinge by an opening located in the center of the lower portion of the leaflets. The ring can include multiple protrusions located along the inner circumference of the ring. The protrusions of the ring limit the opening angle of the leaflets. By limiting the opening angle of the leaflets, wear and tear of the hinges and leaflets, as well as the probability of malfunction of the mechanical prosthetic heart valve are reduced. In addition, limiting the opening angle of the leaflets may increase the opening and closing speed of the leaflets, thus improving performance of the mechanical prosthetic heart valve when the patient is experiencing an elevated cardiac frequency.